Thomas M Estok
1PUBLICATIONS
2CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (1)
Sort by Publication Date:
|Aug 05, 2022
Sirpiglenastat (DRP-104) Induces Antitumor Efficacy through Direct, Broad Antagonism of Glutamine Metabolism and Stimulation of the Innate and Adaptive Immune Systems.Yumi Yokoyama, Thomas M Estok, Robert Wild
Pageof 1
